Qiagen NVNYSE:QGEN
- LAST PRICE40.9600
- TODAY'S CHANGE (%)0.1600 (0.3922%)
- Bid / Lots40.9500/ 7
- Ask / Lots40.9700/ 7
- Open / Previous Close40.6300 / 40.8000
- Day Range
- 52 Week Range
- Volume338,941
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QGEN |
|---|---|---|
| 09:32 ET | 12962 | 40.5 |
| 09:33 ET | 6145 | 40.63 |
| 09:35 ET | 1300 | 40.665 |
| 09:37 ET | 4492 | 40.57 |
| 09:39 ET | 8623 | 40.64 |
| 09:42 ET | 1874 | 40.62 |
| 09:44 ET | 959 | 40.605 |
| 09:46 ET | 300 | 40.63 |
| 09:48 ET | 942 | 40.655 |
| 09:50 ET | 4137 | 40.635 |
| 09:51 ET | 3348 | 40.59 |
| 09:53 ET | 1191 | 40.64 |
| 09:55 ET | 1872 | 40.625 |
| 09:57 ET | 5252 | 40.7 |
| 10:00 ET | 500 | 40.68 |
| 10:02 ET | 892 | 40.67 |
| 10:04 ET | 400 | 40.69 |
| 10:06 ET | 1100 | 40.68 |
| 10:08 ET | 774 | 40.68 |
| 10:09 ET | 243 | 40.6868 |
| 10:11 ET | 1245 | 40.65 |
| 10:13 ET | 1500 | 40.675 |
| 10:15 ET | 1400 | 40.62 |
| 10:18 ET | 1347 | 40.58 |
| 10:20 ET | 1405 | 40.6 |
| 10:22 ET | 1195 | 40.57 |
| 10:24 ET | 2602 | 40.6 |
| 10:26 ET | 1360 | 40.635 |
| 10:27 ET | 3625 | 40.65 |
| 10:29 ET | 400 | 40.65 |
| 10:31 ET | 756 | 40.68 |
| 10:33 ET | 2411 | 40.67 |
| 10:36 ET | 2356 | 40.67 |
| 10:38 ET | 1561 | 40.64 |
| 10:40 ET | 2400 | 40.64 |
| 10:42 ET | 2023 | 40.655 |
| 10:44 ET | 900 | 40.68 |
| 10:45 ET | 2499 | 40.65 |
| 10:47 ET | 1717 | 40.626 |
| 10:49 ET | 15886 | 40.73 |
| 10:51 ET | 1899 | 40.705 |
| 10:54 ET | 1830 | 40.73 |
| 10:56 ET | 1100 | 40.75 |
| 10:58 ET | 3668 | 40.75 |
| 11:00 ET | 6111 | 40.76 |
| 11:02 ET | 725 | 40.78 |
| 11:03 ET | 2600 | 40.81 |
| 11:05 ET | 3513 | 40.76 |
| 11:07 ET | 2258 | 40.74 |
| 11:09 ET | 1800 | 40.715 |
| 11:12 ET | 16582 | 40.745 |
| 11:14 ET | 11511 | 40.73 |
| 11:16 ET | 1306 | 40.725 |
| 11:18 ET | 8638 | 40.76 |
| 11:20 ET | 3073 | 40.75 |
| 11:21 ET | 6051 | 40.7789 |
| 11:23 ET | 1073 | 40.7792 |
| 11:25 ET | 1400 | 40.765 |
| 11:27 ET | 1672 | 40.76 |
| 11:30 ET | 1715 | 40.75 |
| 11:32 ET | 7344 | 40.82 |
| 11:34 ET | 1183 | 40.845 |
| 11:36 ET | 3653 | 40.82 |
| 11:38 ET | 600 | 40.83 |
| 11:39 ET | 1183 | 40.83 |
| 11:41 ET | 805 | 40.87 |
| 11:43 ET | 800 | 40.88 |
| 11:45 ET | 500 | 40.915 |
| 11:48 ET | 1635 | 40.925 |
| 11:50 ET | 512 | 40.92 |
| 11:52 ET | 421 | 40.955 |
| 11:54 ET | 3041 | 40.9417 |
| 11:56 ET | 227 | 40.95 |
| 11:57 ET | 2094 | 40.94 |
| 11:59 ET | 4359 | 40.945 |
| 12:01 ET | 2089 | 40.945 |
| 12:03 ET | 1926 | 40.93 |
| 12:06 ET | 400 | 40.92 |
| 12:08 ET | 100 | 40.92 |
| 12:10 ET | 2320 | 40.87 |
| 12:12 ET | 1200 | 40.85 |
| 12:14 ET | 1381 | 40.85 |
| 12:15 ET | 1600 | 40.83 |
| 12:17 ET | 600 | 40.83 |
| 12:19 ET | 669 | 40.83 |
| 12:21 ET | 2788 | 40.84 |
| 12:24 ET | 1717 | 40.815 |
| 12:26 ET | 967 | 40.83 |
| 12:28 ET | 3982 | 40.87 |
| 12:30 ET | 1317 | 40.9 |
| 12:32 ET | 1380 | 40.92 |
| 12:33 ET | 3334 | 40.98 |
| 12:35 ET | 6459 | 40.99 |
| 12:37 ET | 3821 | 40.96 |
| 12:39 ET | 800 | 40.96 |
| 12:42 ET | 1324 | 40.96 |
Nov 12, 2024
QIAGEN collaborates with McGill University to advance microbiome research, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 6, 2024
*DJ Qiagen 3Q Sales $502M >QGEN, from 4:15PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:15PM ET on Wednesday Nov 06, 2024 by Dow JonesQIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 4, 2024
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics, from 1:30AM ET on Monday Nov 04, 2024 by Dow Jones
1:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 29, 2024
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment, from 2:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
2:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Qiagen NV | 9.1B | 100.4x | +12.66% |
Medpace Holdings Inc | 9.8B | 28.5x | +35.10% |
Exelixis Inc | 9.8B | 21.9x | -21.77% |
Neurocrine Biosciences Inc | 12.1B | 33.0x | +62.04% |
Exact Sciences Corp | 10.0B | -45.1x | --- |
Sarepta Therapeutics Inc | 10.2B | 90.3x | --- |
Company Information
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Contact Information
- Headquarters
- Hulsterweg 82VENLO, Netherlands 5912 PL
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Supervisory Board
- Lawrence Rosen
- Chief Executive Officer, Managing Director, Member of the Executive Board
- Thierry Bernard
- Managing Director, Chief Financial Officer, Member of the Executive Board
- Roland Sackers
- Independent Member of the Supervisory Board
- Metin Colpan
- Independent Member of the Supervisory Board
- Toralf Haag
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.1B |
|---|---|
Revenue (TTM) | $2.0B |
Shares Outstanding | 223.9M |
Qiagen NV does not pay a dividend. | |
Beta | 0.34 |
EPS | $0.41 |
Book Value | $17.20 |
P/E Ratio | 100.4x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 30.2x |
Operating Margin | 4.43% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
